These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6108672)

  • 1. Effects of topical use of beta-adrenoceptor stimulants on nasal mucosa. Rhinomanometric evaluations in experiments with terbutaline and KWD 2131. II. Nasal provocation tests with hay fever patients in asymptomatic period.
    Svensson G
    Acta Otolaryngol; 1980; 90(1-2):130-8. PubMed ID: 6108672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of topical use of beta-adrenoceptor stimulants of nasal mucosa. Rhinomanometric evaluations in experiments with terbutaline and KWD 2131.
    Svensson G; Hegardt B; Löfkvist T
    Acta Otolaryngol; 1980; 90(3-4):297-303. PubMed ID: 6110308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of a beta-adrenoceptor stimulant, KWD 2131, in nasal histamine provocation tests. Rhinomanometric evaluations in normal persons and patients with hay fever.
    Svensson G; Hegardt B; Löfkvist T
    Acta Otolaryngol; 1981; 92(5-6):535-41. PubMed ID: 6171989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical treatment of seasonal allergic rhinitis with a beta-adrenoceptor stimulant (KWD 2131).
    Svensson G
    Rhinology; 1982 Sep; 20(3):159-66. PubMed ID: 6127780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiallergic actions of high topical doses of terbutaline in human nasal airways.
    Svensson C; Greiff L; Andersson M; Alkner U; Grönneberg R; Persson CG
    Allergy; 1995 Nov; 50(11):884-90. PubMed ID: 8748720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective action of fluocortin butylester (FCB) in the nasal antigen provocation test: a controlled double-blind, crossover study.
    Horak F; Matthes H
    Ann Allergy; 1982 May; 48(5):305-8. PubMed ID: 7044195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of sodium cromoglycate on the antigen-induced nasal reaction in allergic rhinitis as measured by rhinomanometry and symptomatology.
    Hasegawa M; Saito Y; Watanabe K
    Clin Allergy; 1976 Jul; 6(4):359-63. PubMed ID: 822964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal challenge with serotonin in asymptomatic hay fever patients.
    Tønnesen P; Schaffalitzky de Muckadell OB; Mygind N
    Allergy; 1987 Aug; 42(6):447-50. PubMed ID: 2444128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the protective effect of a new beta-agonist, KWD 2131, on allergen-induced bronchospasm.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Jul; 35(5):413-9. PubMed ID: 6108726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic blockade does not alter the nasal congestive response to irritant provocation.
    Shusterman D; Murphy MA; Walsh P; Balmes JR
    Rhinology; 2002 Sep; 40(3):141-6. PubMed ID: 12357714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of resistance and capacitance vessels in human nasal mucosa to beta-receptor agonists.
    Konno A; Terada N; Okamoto Y
    ORL J Otorhinolaryngol Relat Spec; 1987; 49(4):206-13. PubMed ID: 2819804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seasonal allergic rhinitis treated with a beta-2-adrenostimulant.
    Borum P; Larsen FS
    Allergy; 1987 Feb; 42(2):141-5. PubMed ID: 3035960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous responses to allergen after local pretreatment with beta-adrenoceptor stimulating and blocking agents.
    Grönneberg R; Strandberg K; Hägermark O
    Allergy; 1980 Jul; 35(5):409-12. PubMed ID: 6108725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cell response in the nasal mucosa in patients with hay fever during plant pollen season].
    Tarchalska-Kryńska B; Zawisza E; Rapiejko P
    Otolaryngol Pol; 1997; 51 Suppl 25():203-6. PubMed ID: 9757693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of KWD 2131, terbutaline, and DSCG on the immediate and late allergen-induced bronchoconstriction.
    Hegardt B; Pauwels R; Van Der Straeten M
    Allergy; 1981 Feb; 36(2):115-22. PubMed ID: 6112931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of oral calcium medication on nasal resistance in the nasal allergen provocation test.
    Bachert C; Drechsler S; Hauser U; Imhoff W; Welzel D
    J Allergy Clin Immunol; 1993 Feb; 91(2):599-604. PubMed ID: 8436775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the inhibition of allergen-induced intracutaneous reactions by a new beta-agonist, KWD 2131, and by terbutaline.
    Hegardt B; Arner B
    Eur J Respir Dis; 1981 Oct; 62(5):352-9. PubMed ID: 6124440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal airway resistance in perennial non-allergic rhinitis. Postural variations and effects of topical application of terbutaline.
    Broms P; Malm L; Svensson G
    Rhinology; 1982 Jun; 20(2):73-9. PubMed ID: 7111988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azelastine reduces histamine-induced swelling of nasal mucosa.
    Spaeth J; Schultze V; Klimek L; Lengersdorf A; Mosges R
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(3):157-63. PubMed ID: 8797220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonspecific nasal mucosal reactivity, expressed as changes in nasal airway resistance after bilateral saline provocation.
    Haavisto L; Sipilä J; Suonpää J
    Am J Rhinol; 1998; 12(4):275-8. PubMed ID: 9740922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.